You can buy or sell PRTK and other stocks, options, and ETFs commission-free!
Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections.
52 Week High
52 Week Low
— per share
Expected May 10, After Hours